The National Center for Advancing Translational Sciences is holding closed meetings to review and evaluate grant applications, as announced under the Federal Advisory Committee Act. These meetings will not be open to the public to protect confidential information related to trade secrets, commercial property, or personal privacy. The first meeting is scheduled for January 2, 2025, focuses on understudied proteins, and the second meeting on January 29, 2025, will review limited competition CTSA R03 applications. Both meetings will take place virtually at the National Institutes of Health in Rockville, MD.
Simple Explanation
In simple terms, the National Center for Advancing Translational Sciences is having special meetings to talk about secret things like science discoveries or business ideas, so only certain people can join these virtual meetings at the NIH in January 2025. They don't explain how they chose these secrets or what happens after the meetings, which might make people wonder if everything is fair.